What was the market valuation of the US tumor ablation market in 2024?

The market valuation of the US tumor ablation market was 367.48 $ Million in 2024. Read More

What is the projected market valuation for the US tumor ablation market by 2035?

The projected market valuation for the US tumor ablation market is 1250.0 $ Million by 2035. Read More

What is the expected CAGR for the US tumor ablation market during the forecast period 2025 - 2035?

The expected CAGR for the US tumor ablation market during the forecast period 2025 - 2035 is 11.77 %. Read More

Which technology segment had the highest valuation in the US tumor ablation market in 2024?

In 2024, the Radiofrequency technology segment had the highest valuation, ranging from 150.0 $ Million to 500.0 $ Million. Read More

What are the projected valuations for the Cryoablation technology segment by 2035?

The projected valuations for the Cryoablation technology segment are expected to range from 67.48 $ Million to 200.0 $ Million by 2035. Read More

Which treatment segment is anticipated to dominate the US tumor ablation market in 2025?

The Percutaneous Ablation treatment segment is anticipated to dominate the US tumor ablation market in 2025, with a valuation range of 150.0 $ Million to 500.0 $ Million. Read More

What is the valuation range for the Lung Cancer application segment in 2024?

The valuation range for the Lung Cancer application segment in 2024 was between 100.0 $ Million and 350.0 $ Million. Read More

Which end user segment is expected to have the highest valuation in 2025?

The Hospitals & Clinics end user segment is expected to have the highest valuation in 2025, ranging from 200.0 $ Million to 700.0 $ Million. Read More

How does the projected growth of the US tumor ablation market compare to its 2024 valuation?

The projected growth of the US tumor ablation market indicates a substantial increase from its 2024 valuation of 367.48 $ Million to 1250.0 $ Million by 2035. Read More

US Tumor Ablation Market

Q: What are the key players in the US tumor ablation market?

Key players in the US tumor ablation market include Medtronic, Boston Scientific, Johnson & Johnson, AngioDynamics, EDAP TMS, Stryker, Hologic, and AtriCure. Read More

ID: MRFR/HC/16523-HCR

100 Pages

Satyendra Maurya

Last Updated: April 06, 2026

United States Tumor Ablation Market Research Report: Size, Share, Trend Analysis By End Users (Hospitals & Clinics, Specialty Centers) By Treatment (Surgical Ablation, Percutaneous Ablation, Laparoscopic Ablation) By Technology (Radiofrequency, Microwave, Irreversible Electroporation, Cryoablation) By Applications (Lung Cancer, Kidney Cancer, Liver Cancer) - Growth Outlook & Industry Forecast 2025 To 2035

US Tumor Ablation Market

Market Size

Forecast Period2025 - 2035

CAGR (2025 - 2035)11.77%

2024 Market Size$ 367.48 Million

2025 Market Size$ 410.73 Million

2035 Market Size$ 1,250 Million

Key Players

Medtronic

Boston Scientific

Johnson & Johnson

AngioDynamics

EDAP TMS

Stryker

Trends

Technological Advancements
Personalized Treatment Approaches
Regulatory Changes and Approvals

Opportunities

Rising Incidence of Cancer
Increased Funding for Cancer Research
Regulatory Support for New Technologies

Summary Table of Contents Segmentation Download PDF

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Chemicals and Materials, BY Technology (USD Million)
  1. 4.1.1 Radiofrequency
  2. 4.1.2 Microwave
  3. 4.1.3 Irreversible Electroporation
  4. 4.1.4 Cryoablation
2. 4.2 Chemicals and Materials, BY Treatment (USD Million)
  1. 4.2.1 Surgical Ablation
  2. 4.2.2 Percutaneous Ablation
  3. 4.2.3 Laparoscopic Ablation
3. 4.3 Chemicals and Materials, BY Application (USD Million)
  1. 4.3.1 Lung Cancer
  2. 4.3.2 Kidney Cancer
  3. 4.3.3 Liver Cancer
4. 4.4 Chemicals and Materials, BY End User (USD Million)
  1. 4.4.1 Hospitals & Clinics
  2. 4.4.2 Specialty Centers
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Chemicals and Materials
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Chemicals and Materials
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Medtronic (IE)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Boston Scientific (US)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Johnson & Johnson (US)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 AngioDynamics (US)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 EDAP TMS (FR)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 Stryker (US)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 Hologic (US)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 AtriCure (US)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 US MARKET ANALYSIS BY TECHNOLOGY
3. 6.3 US MARKET ANALYSIS BY TREATMENT
4. 6.4 US MARKET ANALYSIS BY APPLICATION
5. 6.5 US MARKET ANALYSIS BY END USER
6. 6.6 KEY BUYING CRITERIA OF CHEMICALS AND MATERIALS
7. 6.7 RESEARCH PROCESS OF MRFR
8. 6.8 DRO ANALYSIS OF CHEMICALS AND MATERIALS
9. 6.9 DRIVERS IMPACT ANALYSIS: CHEMICALS AND MATERIALS
10. 6.10 RESTRAINTS IMPACT ANALYSIS: CHEMICALS AND MATERIALS
11. 6.11 SUPPLY / VALUE CHAIN: CHEMICALS AND MATERIALS
12. 6.12 CHEMICALS AND MATERIALS, BY TECHNOLOGY, 2024 (% SHARE)
13. 6.13 CHEMICALS AND MATERIALS, BY TECHNOLOGY, 2024 TO 2035 (USD Million)
14. 6.14 CHEMICALS AND MATERIALS, BY TREATMENT, 2024 (% SHARE)
15. 6.15 CHEMICALS AND MATERIALS, BY TREATMENT, 2024 TO 2035 (USD Million)
16. 6.16 CHEMICALS AND MATERIALS, BY APPLICATION, 2024 (% SHARE)
17. 6.17 CHEMICALS AND MATERIALS, BY APPLICATION, 2024 TO 2035 (USD Million)
18. 6.18 CHEMICALS AND MATERIALS, BY END USER, 2024 (% SHARE)
19. 6.19 CHEMICALS AND MATERIALS, BY END USER, 2024 TO 2035 (USD Million)
20. 6.20 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 US MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY TECHNOLOGY, 2025-2035 (USD Million)
  2. 7.2.2 BY TREATMENT, 2025-2035 (USD Million)
  3. 7.2.3 BY APPLICATION, 2025-2035 (USD Million)
  4. 7.2.4 BY END USER, 2025-2035 (USD Million)
2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.3.1
1. 7.4 ACQUISITION/PARTNERSHIP
7.4.1

Certified Researchers

Customize Report

US Tumor Ablation Market Segmentation

US Tumor Ablation Market By Technology (USD Million, 2025-2035)

Radiofrequency
Microwave
Irreversible Electroporation
Cryoablation

US Tumor Ablation Market By Treatment (USD Million, 2025-2035)

Surgical Ablation
Percutaneous Ablation
Laparoscopic Ablation

US Tumor Ablation Market By Application (USD Million, 2025-2035)

Lung Cancer
Kidney Cancer
Liver Cancer

US Tumor Ablation Market By End User (USD Million, 2025-2035)

Hospitals & Clinics
Specialty Centers

Certified Researchers

Customize Report

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”